Biogen Pharmachem Industries reports standalone net loss of Rs 1.59 crore in the June 2022 quarter
Reported sales nil
Net loss of Biogen Pharmachem Industries reported to Rs 1.59 crore in the quarter ended June 2022 as against net profit of Rs 0.20 crore during the previous quarter ended June 2021. There were no Sales reported in the quarter ended June 2022 as against Rs 1.25 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales01.25 -100 OPM %016.00 -PBDT-1.590.20 PL PBT-1.590.20 PL NP-1.590.20 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content